MedPath

Maximizing CRT Delivery by Using MultipolAr Coronary Sinus Lead FamiLy ACUITY® X4 - RALLY X4 Study

Completed
Conditions
Heartfailure
Registration Number
NCT02066467
Lead Sponsor
Boston Scientific Corporation
Brief Summary

The objective of this study is to collect clinical data on safety and performance of ACUITY X4® leads when used in a standard clinical setting.

It is a prospective, non-randomized, observational multicenter study evaluating standard of care.

For Post Market Clinical Follow up (PMCF) purposes the 3 month implant success rate, adverse events and basic parameters of the lead will be assessed. The cohort of subjects included in this evaluation will be the first 200 subjects which are indicated for PMCF in Rally X4 to receive an ACUITY X4® lead implant.

Study endpoints:

Phrenic Nerve Stimulation (PNS) related CFR through 6 months post-implant (Defined as: rate of freedom from loss of function or operative system revision due to unacceptable PNS threshold) Lead-related Complication-Free Rate (CFR) from Implant through 3 months post-implant.

Detailed Description

Clinic visits will occur at:

* Enrollment and Consenting Clinic Visit (≤ 30 days prior to implant procedure)

* Implant Procedure (Day 0; all future follow ups based on this date)

* Pre-Discharge Clinic Visit (≤ 7 days post implant procedure) (Required)

* One to 6 Month Clinic Visit (20 to 180 days post implant procedure) (Required)

* Interim Visit(s) (Any time between the 1 to 6 Month Clinic Visit and Close-out Clinic Visit) (Following study center specific standard of care) (Device follow up optional) AE - reporting required

* Close-out Clinic Visit (30 months ± 90 days, OR 180 days ± 90 days after the study is closed to enrollment, whichever comes first) (Required)

* During the trial all AEs, deaths, and changes in the device system must be reported

* Devices of subjects who have received a Latitude device will be followed by the Boston Scientific (BSC) Latitude team. Device Data as defined in the Clinical Investigation Plan (CIP), device alerts, and diagnostic data from the standard Latitude database may be collected and entered into the study database at any time.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
863
Inclusion Criteria
  1. Subject is willing and capable of providing informed consent
  2. Subject is planned to be implanted with an ACUITY X4® lead for left-ventricular pacing and sensing via the coronary venous system in conjunction with a compatible BSC pulse generator
  3. Subject is willing and capable of participating in all visits associated with this study at an approved clinical study center and at the intervals defined by this CIP
  4. Subject is age 18 or above, or of legal age to give informed consent specific to state and national law
Exclusion Criteria
  1. Subjects with a hypersensitivity to a maximum single dose of 0.51 mg dexamethasone acetate

  2. Subject is enrolled in any other concurrent study without prior written approval from BSC, with the exception of local mandatory governmental registries and observational studies/registries that are not in conflict and do not affect the following:

    • Schedule of procedures for the RALLY X4 Study (i.e. should not cause additional or missed visits);
    • RALLY X4 Study outcome (i.e. involve medications that could affect the heart rate of the subject);
    • Conduct of the RALLY X4 Study per GCP/ ISO 14155:2011/ local regulations as applicable
  3. Per the implanting physician's discretion, the subject is not a suitable candidate to receive the study device as determined during the implant procedure

  4. Women of childbearing potential who are or might be pregnant at the time of study enrollment or ACUITY X4® lead implant.

  5. Subject is unwilling or unable to participate in all scheduled study follow up visits at an approved study center

  6. Subject does not anticipate being a resident of the area for the scheduled duration of the trial

  7. Subject's physician does not allow participation

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Phrenic Nerve Complication Free Rate6 months post-implant

The Phrenic Nerve Stimulation (PNS) related Complication Free rate (CFR) through 6 months post-implant is defined as the rate of freedom from loss of function or operative system revision due to unacceptable PNS threshold

Secondary Outcome Measures
NameTimeMethod
3 Month Lead-related Complication-Free Rate (CFR)3 months post-implant

Lead-related Complication-Free Rate (CFR) from implant through 3 months post-implant. Lead-related complications associated with the ACUITY X4® lead were counted towards this endpoint.

Trial Locations

Locations (83)

CHU de Grenoble

🇫🇷

Grenoble, France

Klinikum Oldenburg

🇩🇪

Oldenburg, Germany

Waldklinikum Gera

🇩🇪

Gera, Germany

Clinique Pasteur

🇫🇷

Toulouse, France

Unfallkrankenhaus Berlin

🇩🇪

Berlin, Germany

Kansai Rosai Hospital

🇯🇵

Amagasaki-Shi, Japan

Centre Hospitalier de Pau

🇫🇷

Pau, France

Klinikum Kassel

🇩🇪

Kassel, Germany

Krankenhaus Landshut-Achdorf

🇩🇪

Landshut, Germany

University Magdeburg

🇩🇪

Magdeburg, Germany

Deutsches Herzzentrum Berlin

🇩🇪

Berlin, Germany

Centre Hospitalier Régional Universitaire de Lille

🇫🇷

Lille, France

Hôpital de la Timone

🇫🇷

Marseille, France

Herzzentrum Nordrhein-Westfalen

🇩🇪

Bad Oeynhausen, Germany

Clinica Montevergine

🇮🇹

Mercogliano, Italy

Nouvelles Cliniques Nantaises

🇫🇷

Nantes, France

CHU de Rennes

🇫🇷

Rennes, France

CH de Rouen

🇫🇷

Rouen, France

Herz-und Gefäßzentrum Göttingen

🇩🇪

Göttingen, Germany

Hospital Santa Cruz

🇵🇹

Lisbon, Portugal

Ospedale Borgo Trento

🇮🇹

Verona, Italy

Queen Elisabeth Hospital

🇬🇧

Birmingham, United Kingdom

Clínica Universidad de Navarra

🇪🇸

Pamplona, Spain

Hospital Universitario Puerta de Hierro

🇪🇸

Madrid, Spain

Hospital Vírgen de la Salud

🇪🇸

Toledo, Spain

Hospital Sant Pau

🇪🇸

Barcelona, Spain

St Bartholomew's Hospital

🇬🇧

London, United Kingdom

Changi General Hospital

🇸🇬

Singapore, Singapore

Hospital Clinico Valladolid

🇪🇸

Valladolid, Spain

Golden Jubilee National Hospital

🇬🇧

Glasgow, United Kingdom

Hospital Clinic de Barcelona

🇪🇸

Barcelona, Spain

Imperial College Healthcare

🇬🇧

London, United Kingdom

Policlinico Sant'Orsola-Malpighi

🇮🇹

Bologna, Italy

Azienda Ospedaliera Spedali Civili di Brescia

🇮🇹

Brescia, Italy

Policlinico Vittorio Emanuele

🇮🇹

Catania, Italy

Ospedale Pugliese Ciaccio

🇮🇹

Catanzaro, Italy

Azienda Ospedaliera Spedale Sant'Anna di Como

🇮🇹

Como, Italy

Ospedale Santa Maria Misericordia

🇮🇹

Rovigo, Italy

Landesklinikum St.Pölten

🇦🇹

St.Pölten, Austria

Guidant Europe SA / NV a Boston Scientific Company

🇧🇪

Diegem, Belgium

Gentofte Hospital

🇩🇰

Copenhagen, Denmark

Aarhus University Hospital

🇩🇰

Skejby, Denmark

CHU de Clermont-Ferrand

🇫🇷

Clermont-Ferrand, France

Medisch Spectrum Twente

🇳🇱

Enschede, Netherlands

Centro Hospitalar do Porto

🇵🇹

Porto, Portugal

Doce De Octubre University Hospital

🇪🇸

Madrid, Spain

CHU Amiens

🇫🇷

Amiens, France

Centre Hospitalier d'Annecy

🇫🇷

Annecy, France

Waterfort Hospital

🇮🇪

Waterford, Ireland

Kyorin University Hospital

🇯🇵

Mitaka-Shi, Japan

Hospital Rijnstate

🇳🇱

Arnheim, Netherlands

Hospital Santa Maria

🇵🇹

Lisbon, Portugal

Helsinki University Central Hospital

🇫🇮

Helsinki, Finland

Oulu University Hospital

🇫🇮

Oulu, Finland

Beilinson Medical Center

🇮🇱

Petah Tikva, Israel

Osaka Police Hospital

🇯🇵

Osaka-Shi, Japan

Sakurabashi Watanabe Hospital

🇯🇵

Osaka-Shi, Japan

Fundación Valle del Lili

🇨🇴

Cali, Colombia

Clinica Medellin

🇨🇴

Medellin, Colombia

Barzilai Medical Center

🇮🇱

Ashkelon, Israel

Cliniques Universitaires Saint-Luc

🇧🇪

Brussels, Belgium

Fundation Cardioinfantil

🇨🇴

Bogota, Colombia

Isala

🇳🇱

Zwolle, Netherlands

Universitair Ziekenhuis Gent

🇧🇪

Gent, Belgium

Prince of Wales Hospital

🇭🇰

Hong Kong, Hong Kong

Sheba Medical Center

🇮🇱

Ramat Gan, Israel

Shonan Kamakura General Hospital

🇯🇵

Kamakura-Shi, Japan

Kokura Memorial Hospital

🇯🇵

Kitakyushu-Shi, Japan

Kaplan Medical Center

🇮🇱

Rechovot, Israel

Tokai University Hospital

🇯🇵

Isehara-Shi, Japan

Osaka University Hospital

🇯🇵

Suita-Shi, Japan

Yokohama City University Hospital

🇯🇵

Yokohama-Shi, Japan

Tel Aviv Medical Center

🇮🇱

Tel Aviv, Israel

Osaka General Medical Center

🇯🇵

Osaka-Shi, Japan

Osaka Rosai Hospital

🇯🇵

Sakai-Shi, Japan

Hôpital Cantonal de Genève

🇨🇭

Geneva, Switzerland

Medisch Centrum Alkmaar

🇳🇱

Alkmaar, Netherlands

Centro Hospitalar do Alto Ave

🇵🇹

Guimaraes, Portugal

Centro Hospitalar de Vila Nova de Gaia

🇵🇹

Gaia, Portugal

National Heart Centre

🇸🇬

Singapore, Singapore

Institution Kantonsspital St. Gallen

🇨🇭

St. Gallen, Switzerland

Centre Hospitalier Universitaire Vaudois

🇨🇭

Lausanne, Switzerland

Queen Mary Hospital

🇭🇰

Hong Kong, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath